Invasive aspergillosis in human immunodeficiency virus-infected children

被引:50
|
作者
Shetty, D [1 ]
Giri, N [1 ]
Gonzalez, CE [1 ]
Pizzo, PA [1 ]
Walsh, TJ [1 ]
机构
[1] NCI,INFECT DIS SECT,PEDIAT BRANCH,BETHESDA,MD 20892
关键词
acquired immunodeficiency syndrome; aspergillosis; amphotericin E;
D O I
10.1097/00006454-199702000-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Aspergillosis is an uncommon yet serious opportunistic infection in patients with AIDS, It has been extensively reported in HIV-infected adult patients. To our knowledge there are no studies that describe the epidemiology, clinical manifestations and outcome of aspergillosis in a large HIV-infected pediatric population. Methods. We reviewed the records of all 473 HIV-infected children followed in the Pediatric Branch of the National Cancer Institute for 9 years from 1987 through 1995 for the presence of Aspergillus infection. Results. Seven (1.5%) patients developed invasive aspergillosis during the study period. All patients had low CD4 counts reflecting severe immunosuppression. Sustained neutropenia (>7 days) or corticosteroid therapy asa predisposing factor for invasive aspergillosis was encountered in only two patients (28%). Invasive pulmonary aspergillosis developed in five patients and cutaneous aspergillosis in two, The most common presenting features in patients with pulmonary aspergillosis were fever, cough and dyspnea, Patients with cutaneous aspergillosis were diagnosed during life and successfully treated with amphotericin B and surgery, whereas diagnosis of pulmonary aspergillosis was made clinically in only one patient. Conclusions. Aspergillosis is an uncommon but highly lethal opportunistic infection in HIV-infected children. Invasive pulmonary aspergillosis should be considered in the differential diagnosis in febrile, HIV-infected children with persistent pulmonary infiltrates.
引用
收藏
页码:216 / 221
页数:6
相关论文
共 50 条
  • [31] Varicella outbreak at a summer camp for human immunodeficiency virus-infected children
    Winquist, AG
    Roome, A
    Hadler, J
    PEDIATRICS, 2001, 107 (01) : 67 - 72
  • [32] Dideoxyinosine-induced pancreatitis in human immunodeficiency virus-infected children
    Terry L. Levin
    Walter E. Berdon
    H. Babette Tang
    Jack O. Haller
    Pediatric Radiology, 1997, 27 : 189 - 191
  • [33] Endocrinological Abnormalities and Growth Impairment in Human Immunodeficiency Virus-Infected Children
    Pandey, Abhishek
    John, B. M.
    Gupta, Rakesh
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2018, 13 (01) : 63 - 69
  • [34] New challenges in therapeutic management of human immunodeficiency Virus-infected children
    Faye, A.
    ARCHIVES DE PEDIATRIE, 2007, 14 (02): : 212 - 218
  • [35] Nitazoxanide Treatment of Cryptosporidium parvum in Human Immunodeficiency Virus-Infected Children
    Capparelli, Edmund V.
    Syed, Salma S.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (11) : 1041 - 1041
  • [36] Children of human immunodeficiency virus-infected members of the army reserve components
    Cowan, DN
    Gambel, JM
    Brundage, JF
    Garner, RP
    Kuhn, J
    MILITARY MEDICINE, 1997, 162 (12) : 777 - 782
  • [37] Etiology of acute otitis media in human immunodeficiency virus-infected children
    Marchisio, P
    Principi, N
    Sorella, S
    Sala, E
    Tornaghi, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (01) : 58 - 61
  • [38] Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients
    Chin, KM
    Sidhu, JS
    Janssen, RS
    Weber, JT
    OBSTETRICS AND GYNECOLOGY, 1998, 92 (01): : 83 - 87
  • [39] Malignancy in perinatally human immunodeficiency virus-infected children in the United States
    Kest, H
    Brogly, S
    McSherry, G
    Dashefsky, B
    Oleske, J
    Seage, GR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (03) : 237 - 242
  • [40] Impaired phagocyte oxidative capacity in human immunodeficiency virus-infected children
    Hayani, KC
    Verral, SC
    Pitrak, DL
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03): : 584 - 589